Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study
比较在慢性阻塞性肺疾病(COPD)治疗初期使用长效抗胆碱能药物(LAMA)与长效β2受体激动剂/吸入性糖皮质激素(LABA/ICS)的成本和医疗资源利用情况:来自CITRUS(韩国真实世界噻托溴铵和ICS/LABA使用率比较研究)的发现
期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S448492
Choi, Kwang Yong; Kim, Hwan Il; Rhee, Chin Kook; Yoo, Kwang Ha; Park, Yong Bum; Kim, Youlim; Lee, So Eun; Kim, Jung-Ae; Hwang, Yong Il